InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval ...

Nektar Therapeutics may have a pipeline-in-a-drug with rezpegaldesleukin, has additional readouts ahead, and cash until 2027.

A new study from North Carolina State University found that neutrophils—white blood cells that are a key part of the immune ...

The future of dermatology is no longer just skin deep. This year’s American Academy of Dermatology (AAD) annual meeting was held March 7-11, 2025, in Orlando, FL, and it showcased the specialty’s ...

A German multicentre study reveals strong patient demand for systemic therapy in atopic dermatitis and psoriasis. Learn more about treatment preferences and drivers.

New Published Data Confirms Nemluvio® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis ...

Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...

In this video, Gailen D. Marshall Jr., MD, PhD, chair of allergy and immunology at University of Mississippi Medical Center, discusses the clinical development of the nanobody compound lunsekimig for ...

The unique blend of fungi and bacteria in a region's soil may be the strongest factor explaining its rates of childhood ...

No significant differences in the safety or effectiveness of tralokinumab were observed by racial subgroup among patients with AD.

The growing evidence that inflammation is a primary cause of aging skin supports ongoing efforts to study targeted ...

Sleep loss from itching is one of the hardest parts of caring for a child with eczema. Here’s a guide to relieving night flares — and helping the whole family rest easier.